THOMAS BYRNES: Open Payments
NPI 1700509296 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 31 payments from 9 companies in 2025. Trend: 2023 $381 · 2024 $1,451 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $193 |
| Valinor Pharma, LLC | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $62 |
| PFIZER INC. | 3 | $46 |
| Globus Medical, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| AppliedVR Inc | 1 | $16 |
| Tonix Medicines, Inc. | 1 | $15 |
Products named: RELISTOR, MOVANTIK, WAINUA, JOURNAVX, NURTEC ODT, Senza, Belbuca, RelieVRx.
Industry payments across DE — which companies pay providers there.
